Advancements in Cell Membrane-Derived Biomimetic Nanotherapeutics for Breast Cancer DOI Creative Commons

Mingtang Zeng,

Chenji Hu, Tao Chen

et al.

International Journal of Nanomedicine, Journal Year: 2025, Volume and Issue: Volume 20, P. 6059 - 6083

Published: May 1, 2025

Breast cancer remains the leading cause of female mortality worldwide, necessitating innovative and multifaceted approaches to address its various subtypes. Nanotechnology has attracted considerable attention due nanoscale dimensions, diverse carrier types, suitability for hydrophobic drug delivery, capacity controlled targeted administration. Nano-sized particles have become prevalent carriers therapeutic agents targeting breast cancer, thanks their reproducible synthesis adjustable properties, including size, shape, surface characteristics. In addition, certain nanoparticles can enhance effects synergistically. However, immune system often detects removes these nanoparticles, limiting efficacy. As a promising alternative, cell membrane-based delivery systems gained biocompatibility specificity. These membrane-coated are derived from sources, blood cells, stem cells. Leveraging unique properties membranes enables precise tumors associated biomarkers. Inspired by natural structures, disguise in bloodstream, enhancing retention time vivo improving tumor targeting. Consequently, membrane-derived (CMDNPs) been investigated potential applications diagnostics, photothermal therapy (PTT), vaccine development. This review comprehensively explores limitations clinical against cancer.

Language: Английский

Performance evaluation of ciprofloxacin loaded curcumin-exopolysaccharide bioconjugate carrier for eradication of bacterial biofilms DOI

Chandrika Gupta,

Sudip Kumar Ghosh, Ramkrishna Sen

et al.

International Journal of Biological Macromolecules, Journal Year: 2025, Volume and Issue: unknown, P. 142946 - 142946

Published: April 1, 2025

Language: Английский

Citations

0
Improvement of Toughness and Wear Resistance in PBT Composites via Synergistic Reinforcement of Functionalized Phenolic Microspheres and Tungsten Carbide DOI Creative Commons
Jaeyeon Kim,

Jaekyung Lee,

Oju Kwon

et al.

Journal of Materials Research and Technology, Journal Year: 2025, Volume and Issue: unknown

Published: April 1, 2025

Language: Английский

Citations

0
Advancements in Cell Membrane-Derived Biomimetic Nanotherapeutics for Breast Cancer DOI Creative Commons

Mingtang Zeng,

Chenji Hu, Tao Chen

et al.

International Journal of Nanomedicine, Journal Year: 2025, Volume and Issue: Volume 20, P. 6059 - 6083

Published: May 1, 2025

Breast cancer remains the leading cause of female mortality worldwide, necessitating innovative and multifaceted approaches to address its various subtypes. Nanotechnology has attracted considerable attention due nanoscale dimensions, diverse carrier types, suitability for hydrophobic drug delivery, capacity controlled targeted administration. Nano-sized particles have become prevalent carriers therapeutic agents targeting breast cancer, thanks their reproducible synthesis adjustable properties, including size, shape, surface characteristics. In addition, certain nanoparticles can enhance effects synergistically. However, immune system often detects removes these nanoparticles, limiting efficacy. As a promising alternative, cell membrane-based delivery systems gained biocompatibility specificity. These membrane-coated are derived from sources, blood cells, stem cells. Leveraging unique properties membranes enables precise tumors associated biomarkers. Inspired by natural structures, disguise in bloodstream, enhancing retention time vivo improving tumor targeting. Consequently, membrane-derived (CMDNPs) been investigated potential applications diagnostics, photothermal therapy (PTT), vaccine development. This review comprehensively explores limitations clinical against cancer.

Language: Английский

Citations

0